Sign Up to like & get
recommendations!
1
Published in 2017 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2016.10.060
Abstract: We studied fractional Er:YAG laser to enhance transdermal drug delivery of compounds possessing different molecular weights: FITC-dextrans (or FD) with average molecular weights of 4, 10 and 20kDa. Vertical glass Franz diffusion cells were used…
read more here.
Keywords:
laser;
delivery;
fractional yag;
tissue ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noae165.0484
Abstract: Tumor Treating Fields (TTFields) therapy is FDA-approved for glioblastoma. Using plate-based readouts of FITC-dextran fluorescent probes in U87 human glioblastoma cells, we previously reported increased uptake of FITC-dextrans (4-20kDa) post-TTFields exposure. However, this approach is…
read more here.
Keywords:
ttfields exposure;
fitc;
fitc dextrans;
permeabilization ... See more keywords